US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

58.44

+0.11000.19%

Post-market: 58.26-0.1800-0.31%19:30 EDT

Volume:2.37M

Turnover:139.25M

Market Cap:14.48B

PE:18.38

High:59.27

Open:58.47

Low:57.88

Close:58.33

52wk High:61.14

52wk Low:33.76

Shares:247.78M

Float Shares:214.00M

Volume Ratio:1.08

T/O Rate:1.11%

Dividend:- -

Dividend Rate:- -

EPS(TTM):3.18

EPS(LYR):2.78

ROE:44.39%

ROA:23.97%

PB:7.85

PE(LYR):21.02

Loading ...

Overview Company News Filings

Movement Alert｜Exelixis Rises 5.54% in Regular Trading, Trading at $52.88

Exelixis (EXEL) Valuation Check After ASCO 2026 Data Spotlight And New Merck Trial Collaboration

Simply Wall St.

Exelixis to webcast investor conference fireside chats in June

Exelixis EVP Commercial Patrick J. Haley sells 32,110 shares for $1.6 million

Exelixis to present Cabometyx, zanzalintinib studies at ASCO annual meeting

How Investors May Respond To Exelixis (EXEL) Merck MRD+ Colorectal Cancer Trial Collaboration

Simply Wall St.

Top Exelixis Executive Cashes In on Major Stock Sale

Exelixis EVP, CFO Christopher Senner disposes 75,793 shares for $3.78 million

Exelixis SVP, General Counsel Brenda Hefti disposes 13,036 shares worth $662,202.55

Merck to Collaborate With Exelixis on Phase 3 Colorectal Cancer Trial

MT Newswires Live

Exelixis partners with Merck on phase 3 colorectal cancer trial combining zanzalintinib, Keytruda Qlex

Exelixis Inc - Expects to Initiate Stellar-316 in Mid-2026

THOMSON REUTERS

Exelixis Inc - Merck to Supply Keytruda Qlex for Stellar-316 Trial

THOMSON REUTERS

Exelixis Announces Clinical Development Collaboration With Merck for Phase 3 Stellar-316 Pivotal Trial for Patients With Colorectal Cancer

THOMSON REUTERS

Exelixis Advances Zanzalintinib Into Phase 2 Meningioma Trial, Signaling Pipeline Expansion

Exelixis director Mary C. Beckerle disposes 7,712 shares for $373,646.4

Exelixis Director Maria C. Freire disposes 20,634 shares for $949,164

Exelixis director George Poste disposes 60,000 shares for $2.74 million

Exelixis to webcast investor conference fireside chats in May

Exelixis Is Maintained at Buy by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/EXEL/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EXEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","market":"US","secType":"STK","nameCN":"Exelixis","latestPrice":58.44,"timestamp":1791403200000,"preClose":58.33,"halted":0,"volume":2374785,"hourTrading":{"tag":"盘后","latestPrice":58.26,"preClose":58.44,"latestTime":"19:30 EDT","volume":112130,"amount":6552843.47,"timestamp":1791415802027,"change":-0.18,"changeRate":-0.00308,"amplitude":0.00308},"delay":0,"changeRate":0.001885822046974103,"floatShares":214000000,"shares":247781692,"eps":3.18,"marketStatus":"Not Yet Opened","change":0.11,"latestTime":"10-07 16:00:00 EDT","open":58.47,"high":59.265,"low":57.88,"amount":139254851.38005,"amplitude":0.023744,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.18,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791446400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":955425600000,"exchange":"NASDAQ","adjPreClose":58.33,"preHourTrading":{"tag":"盘前","latestPrice":58.47,"preClose":58.33,"latestTime":"09:29 EDT","volume":1649,"amount":96130.275496,"timestamp":1791379799999,"change":0.14,"changeRate":0.0024,"amplitude":0.003429},"postHourTrading":{"tag":"盘后","latestPrice":58.26,"preClose":58.44,"latestTime":"19:30 EDT","volume":112130,"amount":6552843.47,"timestamp":1791415802027,"change":-0.18,"changeRate":-0.00308,"amplitude":0.00308},"volumeRatio":1.077864,"impliedVol":0.4018,"impliedVolPercentile":0.58},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","floatShares":214000000,"roa":"23.97%","roe":"44.39%","lyrEps":2.78,"volumeRatio":1.077864,"shares":247781692,"dividePrice":0,"high":59.265,"amplitude":0.023744,"preClose":58.33,"low":57.88,"week52Low":33.755,"pbRate":"7.85","psRate":"5.94","week52High":61.14,"institutionHeld":0.8319,"latestPrice":58.44,"eps":3.18,"divideRate":0,"volume":2374785,"delay":0,"ttmEps":3.18,"open":58.47,"prevYearClose":43.83,"prevWeekClose":58.39,"prevMonthClose":58.41,"prevQuarterClose":58.41,"fiveDayClose":58.41,"twentyDayClose":58.33,"sixtyDayClose":55.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EXEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"EXEL","fiscalQuarterEnding":"2026/06","expectedEps":0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0.82},{"market":"US","date":"2026-05-05","symbol":"EXEL","fiscalQuarterEnding":"2026/03","expectedEps":0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":0.79},{"market":"US","date":"2026-02-10","symbol":"EXEL","fiscalQuarterEnding":"2025/12","expectedEps":0.68,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2026-01-11","symbol":"EXEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1768107600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"EXEL","fiscalQuarterEnding":"2025/09","expectedEps":0.59,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.67}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EXEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EXEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1053,"buy":0.2632,"hold":0.5789,"sell":0.0526,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5789,"analysts":19,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EXEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EXEL","date":"2026-10-06","current":18.377358,"percent":0.18263,"low":13.520237,"twenty":17.14408,"median":21.43512,"eighty":34.570682,"high":81.497549,"avg":27.709737,"sd":14.890967,"marketCap":14581952574},"quantilePoints":[{"date":"2021-10-08","current":72.42963,"twenty":-27.329077,"median":15.773963,"eighty":43.366777,"marketCap":6811354796},{"date":"2021-10-15","current":73.099654,"twenty":-27.329077,"median":15.952475,"eighty":44.822559,"marketCap":6874364554},{"date":"2021-10-22","current":71.692603,"twenty":-27.329077,"median":16.00116,"eighty":45.312226,"marketCap":6742044063},{"date":"2021-10-29","current":72.061116,"twenty":-27.329077,"median":16.265432,"eighty":45.826118,"marketCap":6776699429},{"date":"2021-11-05","current":37.285528,"twenty":-27.329077,"median":16.391679,"eighty":45.919924,"marketCap":6125452889},{"date":"2021-11-12","current":34.858887,"twenty":-27.329077,"median":16.479897,"eighty":45.919924,"marketCap":5726792216},{"date":"2021-11-19","current":34.724073,"twenty":-27.329077,"median":16.682751,"eighty":45.919924,"marketCap":5704644400},{"date":"2021-11-26","current":32.855945,"twenty":-27.200425,"median":16.81027,"eighty":45.919924,"marketCap":5397738961},{"date":"2021-12-03","current":30.506341,"twenty":-26.943119,"median":16.933764,"eighty":45.919924,"marketCap":5011734182},{"date":"2021-12-10","current":32.066324,"twenty":-26.245177,"median":17.104522,"eighty":45.919924,"marketCap":5268016044},{"date":"2021-12-17","current":35.051477,"twenty":-24.694911,"median":17.218287,"eighty":45.919924,"marketCap":5758431952},{"date":"2021-12-23","current":37.131455,"twenty":-24.254275,"median":17.32582,"eighty":45.919924,"marketCap":6100141100},{"date":"2021-12-31","current":35.20555,"twenty":7.517288,"median":17.464132,"eighty":45.919924,"marketCap":5783743740},{"date":"2022-01-07","current":36.091466,"twenty":7.709485,"median":17.687208,"eighty":45.891374,"marketCap":5929286526},{"date":"2022-01-14","current":34.897405,"twenty":7.799575,"median":17.756166,"eighty":45.891374,"marketCap":5733120163},{"date":"2022-01-21","current":33.356681,"twenty":7.907699,"median":17.862859,"eighty":45.891374,"marketCap":5480002275},{"date":"2022-01-28","current":34.223338,"twenty":7.943549,"median":18.081923,"eighty":45.891374,"marketCap":5622381087},{"date":"2022-02-04","current":36.187761,"twenty":8.039903,"median":18.360975,"eighty":45.891374,"marketCap":5945106394},{"date":"2022-02-11","current":36.110725,"twenty":8.136529,"median":18.515656,"eighty":45.891374,"marketCap":5932450500},{"date":"2022-02-18","current":27.042003,"twenty":8.217909,"median":18.789229,"eighty":45.891374,"marketCap":6248406283},{"date":"2022-02-25","current":27.899162,"twenty":8.270506,"median":18.897922,"eighty":45.891374,"marketCap":6446464151},{"date":"2022-03-04","current":28.61807,"twenty":8.371042,"median":19.106053,"eighty":45.891374,"marketCap":6612577201},{"date":"2022-03-11","current":29.019,"twenty":8.507031,"median":19.335948,"eighty":45.891374,"marketCap":6705217172},{"date":"2022-03-18","current":29.572006,"twenty":8.621808,"median":21.199768,"eighty":45.891374,"marketCap":6832996441},{"date":"2022-03-25","current":30.249439,"twenty":8.73225,"median":22.506564,"eighty":45.891374,"marketCap":6989526047},{"date":"2022-04-01","current":31.645779,"twenty":8.756029,"median":22.697854,"eighty":45.891374,"marketCap":7312168702},{"date":"2022-04-08","current":31.825506,"twenty":8.792498,"median":22.852188,"eighty":45.891374,"marketCap":7353696965},{"date":"2022-04-14","current":31.995647,"twenty":8.865935,"median":22.952956,"eighty":45.891374,"marketCap":7393010230},{"date":"2022-04-22","current":31.067233,"twenty":8.939729,"median":23.213643,"eighty":45.891374,"marketCap":7178488062},{"date":"2022-04-29","current":30.956378,"twenty":8.974263,"median":23.420305,"eighty":45.891374,"marketCap":7152873475},{"date":"2022-05-06","current":29.778539,"twenty":9.039592,"median":23.531551,"eighty":45.891374,"marketCap":6880718486},{"date":"2022-05-13","current":21.60979,"twenty":9.09473,"median":23.549925,"eighty":45.891374,"marketCap":6440473677},{"date":"2022-05-20","current":19.113041,"twenty":9.107191,"median":23.549925,"eighty":45.891374,"marketCap":5696355204},{"date":"2022-05-27","current":19.801799,"twenty":9.125872,"median":23.549925,"eighty":45.891374,"marketCap":5901629266},{"date":"2022-06-03","current":20.490558,"twenty":9.145972,"median":23.549925,"eighty":45.891374,"marketCap":6106903327},{"date":"2022-06-10","current":19.521991,"twenty":9.183299,"median":23.549925,"eighty":45.891374,"marketCap":5818236678},{"date":"2022-06-17","current":19.973989,"twenty":9.197529,"median":23.549925,"eighty":45.891374,"marketCap":5952947781},{"date":"2022-06-24","current":23.912825,"twenty":9.237499,"median":23.564333,"eighty":45.919924,"marketCap":7126858820},{"date":"2022-07-01","current":23.213305,"twenty":9.247736,"median":23.584442,"eighty":45.919924,"marketCap":6918377351},{"date":"2022-07-08","current":23.686826,"twenty":9.281845,"median":23.611294,"eighty":45.919924,"marketCap":7059503269},{"date":"2022-07-15","current":22.965782,"twenty":9.328108,"median":23.611294,"eighty":45.919924,"marketCap":6844606986},{"date":"2022-07-22","current":22.449214,"twenty":9.353834,"median":23.633017,"eighty":45.919924,"marketCap":6690651440},{"date":"2022-07-29","current":22.513785,"twenty":9.38718,"median":23.633017,"eighty":45.919924,"marketCap":6709895883},{"date":"2022-08-05","current":23.159496,"twenty":9.423477,"median":23.633017,"eighty":45.919924,"marketCap":6902340315},{"date":"2022-08-12","current":22.996839,"twenty":9.477679,"median":23.677084,"eighty":45.919924,"marketCap":6269283152},{"date":"2022-08-19","current":22.819758,"twenty":9.532448,"median":23.677084,"eighty":45.919924,"marketCap":6221008384},{"date":"2022-08-26","current":21.521169,"twenty":9.589879,"median":23.677084,"eighty":45.919924,"marketCap":5866993422},{"date":"2022-09-02","current":21.143397,"twenty":9.637235,"median":23.677084,"eighty":45.919924,"marketCap":5764007251},{"date":"2022-09-09","current":21.131592,"twenty":9.656291,"median":23.677084,"eighty":45.919924,"marketCap":5760788933},{"date":"2022-09-16","current":20.24619,"twenty":9.709392,"median":23.677084,"eighty":45.919924,"marketCap":5519415095},{"date":"2022-09-23","current":19.219124,"twenty":9.737158,"median":23.677084,"eighty":45.919924,"marketCap":5239421443},{"date":"2022-09-30","current":18.510802,"twenty":9.752596,"median":23.677084,"eighty":45.919924,"marketCap":5046322373},{"date":"2022-10-07","current":18.180252,"twenty":9.809283,"median":23.677084,"eighty":45.919924,"marketCap":4956209473},{"date":"2022-10-14","current":18.475386,"twenty":9.839263,"median":23.677084,"eighty":45.919924,"marketCap":5036667419},{"date":"2022-10-21","current":19.419815,"twenty":9.921087,"median":23.677084,"eighty":45.919924,"marketCap":5294132846},{"date":"2022-10-28","current":19.632311,"twenty":9.95111,"median":23.677084,"eighty":45.919924,"marketCap":5352062567},{"date":"2022-11-04","current":17.259423,"twenty":9.977849,"median":23.677084,"eighty":45.919924,"marketCap":5309360940},{"date":"2022-11-11","current":17.615936,"twenty":10.045835,"median":23.677084,"eighty":45.919924,"marketCap":5419031822},{"date":"2022-11-18","current":17.731278,"twenty":10.09551,"median":23.677084,"eighty":45.919924,"marketCap":5454513578},{"date":"2022-11-25","current":17.762735,"twenty":10.137764,"median":23.677084,"eighty":45.919924,"marketCap":5464190420},{"date":"2022-12-02","current":18.234591,"twenty":10.262522,"median":23.677084,"eighty":45.919924,"marketCap":5609343059},{"date":"2022-12-09","current":16.535911,"twenty":10.306552,"median":23.677084,"eighty":45.919924,"marketCap":5086793561},{"date":"2022-12-16","current":16.714168,"twenty":10.501618,"median":23.677084,"eighty":45.919924,"marketCap":5141629002},{"date":"2022-12-23","current":16.598825,"twenty":10.590509,"median":23.677084,"eighty":45.919924,"marketCap":5106147246},{"date":"2022-12-30","current":16.819025,"twenty":10.667114,"median":23.677084,"eighty":45.919924,"marketCap":5173885144},{"date":"2023-01-06","current":18.108763,"twenty":10.667114,"median":23.584442,"eighty":45.49168,"marketCap":5570635688},{"date":"2023-01-13","current":17.227966,"twenty":10.667114,"median":23.503875,"eighty":45.1654,"marketCap":5299684097},{"date":"2023-01-20","current":17.542536,"twenty":10.667114,"median":23.449537,"eighty":44.010071,"marketCap":5396452523},{"date":"2023-01-27","current":18.318476,"twenty":10.667114,"median":23.314972,"eighty":43.020435,"marketCap":5635147972},{"date":"2023-02-03","current":18.402362,"twenty":10.667114,"median":23.194326,"eighty":42.458135,"marketCap":5660952885},{"date":"2023-02-10","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":42.011762,"marketCap":5687732764},{"date":"2023-02-17","current":31.096255,"twenty":10.667114,"median":23.191781,"eighty":41.420955,"marketCap":5668287524},{"date":"2023-02-24","current":30.456195,"twenty":10.667114,"median":23.191781,"eighty":41.184268,"marketCap":5551616082},{"date":"2023-03-03","current":30.491754,"twenty":10.667114,"median":23.191781,"eighty":40.984929,"marketCap":5558097829},{"date":"2023-03-10","current":29.65612,"twenty":10.667114,"median":23.191781,"eighty":40.686627,"marketCap":5405776781},{"date":"2023-03-17","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":40.243946,"marketCap":5687732764},{"date":"2023-03-24","current":32.85642,"twenty":10.667114,"median":23.191781,"eighty":39.955417,"marketCap":5989133987},{"date":"2023-03-31","current":34.509909,"twenty":10.667928,"median":23.193053,"eighty":39.475483,"marketCap":6290535211},{"date":"2023-04-06","current":35.363322,"twenty":10.667928,"median":23.193053,"eighty":39.271956,"marketCap":6446097132},{"date":"2023-04-14","current":34.918836,"twenty":10.667114,"median":23.191781,"eighty":39.023166,"marketCap":6365075298},{"date":"2023-04-21","current":33.620936,"twenty":10.667114,"median":23.191781,"eighty":38.427704,"marketCap":6128491542},{"date":"2023-04-28","current":32.305257,"twenty":10.667114,"median":23.191781,"eighty":37.395181,"marketCap":5888666913},{"date":"2023-05-05","current":34.73643,"twenty":10.667114,"median":23.191781,"eighty":37.193084,"marketCap":6331825854},{"date":"2023-05-12","current":40.911234,"twenty":10.667114,"median":23.213305,"eighty":37.526354,"marketCap":6289570343},{"date":"2023-05-19","current":41.790934,"twenty":10.666299,"median":23.203815,"eighty":38.431783,"marketCap":6424812840},{"date":"2023-05-26","current":40.308235,"twenty":10.666299,"median":23.203815,"eighty":39.03948,"marketCap":6196867124},{"date":"2023-05-31","current":40.265872,"twenty":10.666299,"median":23.203815,"eighty":39.188346,"marketCap":6190354389},{"date":"2023-06-09","current":40.98604,"twenty":10.659474,"median":23.193053,"eighty":39.394311,"marketCap":6301070880},{"date":"2023-06-16","current":40.456505,"twenty":10.636307,"median":23.23296,"eighty":39.77769,"marketCap":6219661695},{"date":"2023-06-22","current":40.265872,"twenty":10.614439,"median":23.277876,"eighty":40.236218,"marketCap":6190354389},{"date":"2023-06-26","current":42.066293,"twenty":10.603505,"median":23.311527,"eighty":40.265872,"marketCap":6467145616},{"date":"2023-07-07","current":40.943677,"twenty":10.600095,"median":23.213305,"eighty":40.520035,"marketCap":6294558145},{"date":"2023-07-14","current":40.98604,"twenty":10.600095,"median":23.213305,"eighty":40.545455,"marketCap":6301070880},{"date":"2023-07-21","current":42.087474,"twenty":10.600095,"median":23.213305,"eighty":40.680159,"marketCap":6470401984},{"date":"2023-07-28","current":41.515576,"twenty":10.600095,"median":23.213305,"eighty":40.924511,"marketCap":6382480064},{"date":"2023-08-04","current":40.24272,"twenty":10.600095,"median":23.354574,"eighty":40.932036,"marketCap":6609585096},{"date":"2023-08-11","current":40.998725,"twenty":10.600095,"median":23.481924,"eighty":40.941559,"marketCap":6733753602},{"date":"2023-08-18","current":40.707954,"twenty":10.600095,"median":23.579987,"eighty":40.983764,"marketCap":6685996485},{"date":"2023-08-25","current":42.161809,"twenty":10.600095,"median":23.703849,"eighty":41.024602,"marketCap":6924782073},{"date":"2023-09-01","current":43.402433,"twenty":10.600095,"median":23.784876,"eighty":41.205168,"marketCap":7128545776},{"date":"2023-09-08","current":42.685197,"twenty":10.600095,"median":23.881479,"eighty":41.417849,"marketCap":7010744885},{"date":"2023-09-15","current":43.169816,"twenty":10.600095,"median":23.959006,"eighty":41.704282,"marketCap":7090340081},{"date":"2023-09-22","current":41.832269,"twenty":10.600095,"median":24.063445,"eighty":41.742049,"marketCap":6870657340},{"date":"2023-09-29","current":43.402433,"twenty":10.600095,"median":24.159779,"eighty":41.859163,"marketCap":7128545776},{"date":"2023-10-06","current":42.917814,"twenty":10.600095,"median":24.411169,"eighty":41.925256,"marketCap":7048950579},{"date":"2023-10-13","current":41.173188,"twenty":10.600095,"median":24.472259,"eighty":41.970666,"marketCap":6762407873},{"date":"2023-10-20","current":40.378413,"twenty":10.600095,"median":24.601456,"eighty":42.032402,"marketCap":6631871751},{"date":"2023-10-27","current":40.688569,"twenty":10.590509,"median":24.763289,"eighty":42.053584,"marketCap":6682812677},{"date":"2023-11-03","current":67.987802,"twenty":10.590509,"median":24.82708,"eighty":42.104419,"marketCap":6259908894},{"date":"2023-11-10","current":70.993721,"twenty":10.590509,"median":24.916894,"eighty":42.169563,"marketCap":6536675855},{"date":"2023-11-17","current":70.858623,"twenty":10.590509,"median":25.114925,"eighty":42.251018,"marketCap":6524236890},{"date":"2023-11-24","current":73.222829,"twenty":10.590509,"median":25.234082,"eighty":42.431195,"marketCap":6741918769},{"date":"2023-12-01","current":73.661896,"twenty":10.590509,"median":25.380185,"eighty":42.822269,"marketCap":6782345404},{"date":"2023-12-08","current":74.269835,"twenty":10.594875,"median":25.475549,"eighty":42.99923,"marketCap":6838320744},{"date":"2023-12-15","current":78.728051,"twenty":10.594875,"median":25.683605,"eighty":43.169816,"marketCap":7248806574},{"date":"2023-12-22","current":79.302215,"twenty":10.594875,"median":25.809174,"eighty":43.432834,"marketCap":7301672173},{"date":"2023-12-29","current":81.497549,"twenty":10.590509,"median":25.871438,"eighty":43.801759,"marketCap":7503805346},{"date":"2024-01-05","current":79.741282,"twenty":10.586142,"median":26.026128,"eighty":45.173557,"marketCap":7342098807},{"date":"2024-01-12","current":75.688358,"twenty":10.586142,"median":26.123266,"eighty":45.499837,"marketCap":6968929872},{"date":"2024-01-19","current":75.215517,"twenty":10.581776,"median":26.310309,"eighty":46.429737,"marketCap":6925393496},{"date":"2024-01-26","current":74.607578,"twenty":10.586142,"median":26.757641,"eighty":47.070063,"marketCap":6869418156},{"date":"2024-02-02","current":73.45925,"twenty":10.586142,"median":26.8819,"eighty":48.970648,"marketCap":6763686957},{"date":"2024-02-09","current":29.434352,"twenty":10.586142,"median":27.133306,"eighty":50.736642,"marketCap":6115428204},{"date":"2024-02-16","current":30.047264,"twenty":10.666299,"median":27.737543,"eighty":50.736642,"marketCap":6242769792},{"date":"2024-02-23","current":30.222382,"twenty":10.755729,"median":28.081886,"eighty":50.736642,"marketCap":6279153103},{"date":"2024-03-01","current":31.958965,"twenty":12.580654,"median":28.465994,"eighty":50.389968,"marketCap":6639954272},{"date":"2024-03-08","current":32.236234,"twenty":14.477572,"median":28.687196,"eighty":50.389968,"marketCap":6697561181},{"date":"2024-03-15","current":32.995077,"twenty":15.693391,"median":29.087177,"eighty":50.389968,"marketCap":6855222195},{"date":"2024-03-22","current":34.906778,"twenty":16.21505,"median":29.378454,"eighty":50.389968,"marketCap":7252406675},{"date":"2024-03-28","current":34.819219,"twenty":16.431775,"median":29.448945,"eighty":50.389968,"marketCap":7234215019},{"date":"2024-04-05","current":34.279273,"twenty":16.579951,"median":29.605173,"eighty":50.736642,"marketCap":7122033143},{"date":"2024-04-12","current":33.05345,"twenty":16.813772,"median":29.772048,"eighty":50.736642,"marketCap":6867349966},{"date":"2024-04-19","current":31.911299,"twenty":16.916749,"median":30.058488,"eighty":50.736642,"marketCap":6630050987},{"date":"2024-04-26","current":33.386966,"twenty":17.091652,"median":30.249439,"eighty":50.389968,"marketCap":6936642941},{"date":"2024-05-03","current":31.422916,"twenty":17.176551,"median":30.506341,"eighty":50.389968,"marketCap":6443394612},{"date":"2024-05-10","current":30.911512,"twenty":17.328629,"median":30.882901,"eighty":50.389968,"marketCap":6338529239},{"date":"2024-05-17","current":30.158612,"twenty":17.488992,"median":30.882901,"eighty":50.389968,"marketCap":6184144105},{"date":"2024-05-24","current":28.993748,"twenty":17.580284,"median":30.882901,"eighty":50.389968,"marketCap":5945284088},{"date":"2024-05-31","current":30.812073,"twenty":17.615936,"median":30.882901,"eighty":50.389968,"marketCap":6318138749},{"date":"2024-06-07","current":31.08198,"twenty":17.668364,"median":30.954522,"eighty":50.389968,"marketCap":6373484363},{"date":"2024-06-14","current":30.883101,"twenty":17.731278,"median":31.025137,"eighty":50.389968,"marketCap":6332703384},{"date":"2024-06-21","current":31.536561,"twenty":17.769898,"median":31.042917,"eighty":50.736642,"marketCap":6466698028},{"date":"2024-06-28","current":31.920114,"twenty":17.8613,"median":31.103323,"eighty":50.736642,"marketCap":6545347058},{"date":"2024-07-05","current":31.394505,"twenty":18.024877,"median":31.149457,"eighty":50.736642,"marketCap":6437568758},{"date":"2024-07-12","current":31.820674,"twenty":18.175107,"median":31.199278,"eighty":50.736642,"marketCap":6524956569},{"date":"2024-07-19","current":32.104788,"twenty":18.272126,"median":31.292005,"eighty":50.736642,"marketCap":6583215110},{"date":"2024-07-26","current":33.227035,"twenty":18.414252,"median":31.360962,"eighty":50.736642,"marketCap":6813336346},{"date":"2024-08-02","current":34.335076,"twenty":18.480333,"median":31.430019,"eighty":50.736642,"marketCap":7040544655},{"date":"2024-08-09","current":21.981185,"twenty":18.723299,"median":31.444483,"eighty":50.736642,"marketCap":7693239023},{"date":"2024-08-16","current":21.475871,"twenty":18.914042,"median":31.444483,"eighty":50.736642,"marketCap":7516382953},{"date":"2024-08-23","current":21.09281,"twenty":19.069994,"median":31.444483,"eighty":50.736642,"marketCap":7382314643},{"date":"2024-08-30","current":21.215063,"twenty":19.173593,"median":31.444483,"eighty":50.736642,"marketCap":7425102401},{"date":"2024-09-06","current":20.497842,"twenty":19.271067,"median":31.444483,"eighty":50.736642,"marketCap":7174080883},{"date":"2024-09-13","current":21.565523,"twenty":19.391482,"median":31.444483,"eighty":50.736642,"marketCap":7547760643},{"date":"2024-09-20","current":21.532922,"twenty":19.566201,"median":31.444483,"eighty":50.736642,"marketCap":7536350574},{"date":"2024-09-27","current":21.158012,"twenty":19.756599,"median":31.444483,"eighty":50.736642,"marketCap":7405134781},{"date":"2024-10-04","current":21.728528,"twenty":20.051881,"median":31.444483,"eighty":50.736642,"marketCap":7604810988},{"date":"2024-10-11","current":21.378068,"twenty":20.260356,"median":31.444483,"eighty":50.736642,"marketCap":7482152746},{"date":"2024-10-18","current":23.554181,"twenty":20.577253,"median":31.444483,"eighty":50.736642,"marketCap":8243774852},{"date":"2024-10-25","current":22.714707,"twenty":20.830566,"median":31.444483,"eighty":50.736642,"marketCap":7949965575},{"date":"2024-11-01","current":20.868399,"twenty":20.870141,"median":31.444483,"eighty":50.736642,"marketCap":9743956162},{"date":"2024-11-08","current":22.171145,"twenty":20.970556,"median":31.444483,"eighty":50.736642,"marketCap":10352239475},{"date":"2024-11-15","current":21.070232,"twenty":21.016922,"median":31.444483,"eighty":50.736642,"marketCap":9838197239},{"date":"2024-11-22","current":21.779709,"twenty":21.079263,"median":31.444483,"eighty":50.736642,"marketCap":10169468902},{"date":"2024-11-29","current":22.299584,"twenty":21.136314,"median":31.444483,"eighty":50.736642,"marketCap":10412211069},{"date":"2024-12-06","current":21.908149,"twenty":21.209839,"median":31.444483,"eighty":50.736642,"marketCap":10229440496},{"date":"2024-12-13","current":21.424971,"twenty":21.270039,"median":31.444483,"eighty":50.736642,"marketCap":10003833070},{"date":"2024-12-20","current":20.360756,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9506925575},{"date":"2024-12-27","current":20.678797,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9655426666},{"date":"2025-01-03","current":20.776656,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9701119309},{"date":"2025-01-10","current":22.030472,"twenty":21.317067,"median":31.451844,"eighty":51.083315,"marketCap":10286556300},{"date":"2025-01-17","current":22.140564,"twenty":21.392738,"median":31.451844,"eighty":51.083315,"marketCap":10337960524},{"date":"2025-01-24","current":19.804184,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9247048667},{"date":"2025-01-31","current":20.275129,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9466944513},{"date":"2025-02-07","current":20.476963,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9561185589},{"date":"2025-02-14","current":18.792386,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9795850750},{"date":"2025-02-21","current":19.785698,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10313631432},{"date":"2025-02-28","current":20.773641,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10828613300},{"date":"2025-03-07","current":20.714579,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10797826341},{"date":"2025-03-14","current":19.678313,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10257655142},{"date":"2025-03-21","current":19.84476,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10344418392},{"date":"2025-03-28","current":19.705159,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10271649215},{"date":"2025-04-04","current":18.561508,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":9675501726},{"date":"2025-04-11","current":18.958833,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9882613999},{"date":"2025-04-17","current":19.324707,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10073332113},{"date":"2025-04-25","current":19.986841,"twenty":21.378068,"median":31.451844,"eighty":51.429988,"marketCap":10418480823},{"date":"2025-05-02","current":21.145576,"twenty":21.26595,"median":31.451844,"eighty":51.429988,"marketCap":11022491066},{"date":"2025-05-09","current":19.314028,"twenty":21.215063,"median":31.451844,"eighty":51.429988,"marketCap":10067765198},{"date":"2025-05-16","current":19.238052,"twenty":21.149861,"median":31.451844,"eighty":51.429988,"marketCap":12380955912},{"date":"2025-05-23","current":18.161738,"twenty":21.100813,"median":31.451844,"eighty":51.429988,"marketCap":11688276880},{"date":"2025-05-30","current":18.051564,"twenty":21.052058,"median":31.451844,"eighty":51.429988,"marketCap":11617372728},{"date":"2025-06-06","current":17.954102,"twenty":21.011307,"median":31.451844,"eighty":51.429988,"marketCap":11554649823},{"date":"2025-06-13","current":17.704092,"twenty":20.970556,"median":31.451844,"eighty":51.429988,"marketCap":11393751938},{"date":"2025-06-20","current":17.263397,"twenty":20.919812,"median":31.451844,"eighty":52.534404,"marketCap":11110135327},{"date":"2025-06-27","current":18.259199,"twenty":20.836957,"median":31.451844,"eighty":52.534404,"marketCap":11750999785},{"date":"2025-07-03","current":19.555861,"twenty":20.776053,"median":31.451844,"eighty":52.534404,"marketCap":12585487122},{"date":"2025-07-11","current":19.14059,"twenty":20.723755,"median":31.451844,"eighty":52.534404,"marketCap":12318233007},{"date":"2025-07-18","current":19.013466,"twenty":20.683176,"median":31.451844,"eighty":52.534404,"marketCap":12236420523},{"date":"2025-07-25","current":18.979567,"twenty":20.586623,"median":31.451844,"eighty":52.534404,"marketCap":12214603861},{"date":"2025-08-01","current":16.188856,"twenty":20.513914,"median":31.451844,"eighty":52.534404,"marketCap":9750515310},{"date":"2025-08-08","current":16.711798,"twenty":20.476963,"median":31.451844,"eighty":52.534404,"marketCap":10065482260},{"date":"2025-08-15","current":17.194513,"twenty":20.30571,"median":31.451844,"eighty":52.534404,"marketCap":10356220982},{"date":"2025-08-22","current":17.301783,"twenty":20.251749,"median":31.451844,"eighty":52.534404,"marketCap":10420829587},{"date":"2025-08-29","current":16.939747,"twenty":20.21434,"median":31.451844,"eighty":52.534404,"marketCap":10202775545},{"date":"2025-09-05","current":16.707328,"twenty":20.146713,"median":31.458689,"eighty":53.63882,"marketCap":10062790234},{"date":"2025-09-12","current":17.462689,"twenty":19.984406,"median":31.451844,"eighty":52.534404,"marketCap":10517742495},{"date":"2025-09-19","current":18.079492,"twenty":19.948593,"median":31.451844,"eighty":52.534404,"marketCap":10889241974},{"date":"2025-09-26","current":17.292844,"twenty":19.877101,"median":31.451844,"eighty":52.534404,"marketCap":10415445537},{"date":"2025-10-03","current":18.481755,"twenty":19.840807,"median":31.451844,"eighty":52.534404,"marketCap":11131524243},{"date":"2025-10-10","current":17.239209,"twenty":19.803707,"median":31.451844,"eighty":52.534404,"marketCap":10383141234},{"date":"2025-10-17","current":17.525263,"twenty":19.742534,"median":31.451844,"eighty":52.534404,"marketCap":10555430848},{"date":"2025-10-24","current":17.006791,"twenty":19.679289,"median":31.451844,"eighty":52.534404,"marketCap":10243155924},{"date":"2025-10-31","current":17.404584,"twenty":19.615895,"median":31.451844,"eighty":52.534404,"marketCap":10482746167},{"date":"2025-11-07","current":16.202116,"twenty":19.555861,"median":31.437122,"eighty":52.534404,"marketCap":10983462856},{"date":"2025-11-14","current":16.817637,"twenty":19.509455,"median":31.380299,"eighty":52.534404,"marketCap":11400726764},{"date":"2025-11-21","current":16.591284,"twenty":19.373439,"median":31.295065,"eighty":52.534404,"marketCap":11247281327},{"date":"2025-11-28","current":17.540379,"twenty":19.314266,"median":31.202932,"eighty":52.534404,"marketCap":11890675352},{"date":"2025-12-05","current":17.619801,"twenty":19.287595,"median":31.161149,"eighty":52.534404,"marketCap":11944515856},{"date":"2025-12-12","current":16.436411,"twenty":19.234266,"median":31.110391,"eighty":52.534404,"marketCap":11142292344},{"date":"2025-12-19","current":16.905002,"twenty":19.13508,"median":31.060696,"eighty":52.534404,"marketCap":11459951318},{"date":"2025-12-26","current":18.469618,"twenty":19.091517,"median":30.989578,"eighty":52.534404,"marketCap":12520609251},{"date":"2026-01-02","current":17.405361,"twenty":19.012619,"median":30.926871,"eighty":52.534404,"marketCap":11799146495},{"date":"2026-01-09","current":17.532437,"twenty":18.97458,"median":30.882901,"eighty":52.534404,"marketCap":11885291302},{"date":"2026-01-16","current":18.044709,"twenty":18.899845,"median":30.670016,"eighty":50.234126,"marketCap":12232562554},{"date":"2026-01-23","current":17.671425,"twenty":18.838561,"median":30.491754,"eighty":50.234126,"marketCap":11979512184},{"date":"2026-01-30","current":16.78984,"twenty":18.766673,"median":30.249439,"eighty":50.234126,"marketCap":11381882587},{"date":"2026-02-06","current":16.825579,"twenty":18.695068,"median":30.105636,"eighty":50.234126,"marketCap":11406110814},{"date":"2026-02-13","current":14.170695,"twenty":18.554438,"median":29.889985,"eighty":43.40631,"marketCap":11089561020},{"date":"2026-02-20","current":14.65522,"twenty":18.504467,"median":29.831882,"eighty":43.092277,"marketCap":11468735706},{"date":"2026-02-27","current":14.695044,"twenty":18.475686,"median":29.755401,"eighty":42.964338,"marketCap":11499900748},{"date":"2026-03-06","current":13.699445,"twenty":18.456655,"median":29.521911,"eighty":42.638674,"marketCap":10720774681},{"date":"2026-03-13","current":13.66294,"twenty":18.41075,"median":29.44758,"eighty":42.285872,"marketCap":10692206726},{"date":"2026-03-20","current":13.692808,"twenty":18.342542,"median":29.115776,"eighty":42.161809,"marketCap":10715580508},{"date":"2026-03-27","current":14.057861,"twenty":18.259199,"median":28.993748,"eighty":42.049347,"marketCap":11001260066},{"date":"2026-04-02","current":14.615396,"twenty":18.234428,"median":28.687196,"eighty":41.878613,"marketCap":11437570663},{"date":"2026-04-10","current":15.070053,"twenty":18.171384,"median":28.383043,"eighty":41.791447,"marketCap":11793371567},{"date":"2026-04-17","current":14.728231,"twenty":18.108763,"median":27.097303,"eighty":41.696576,"marketCap":11525871617},{"date":"2026-04-24","current":14.947003,"twenty":18.071285,"median":24.862085,"eighty":41.545375,"marketCap":11697076412},{"date":"2026-05-01","current":14.430918,"twenty":18.014311,"median":23.686826,"eighty":41.386833,"marketCap":11293203416},{"date":"2026-05-08","current":13.936676,"twenty":17.953577,"median":23.497129,"eighty":41.036876,"marketCap":11615118385},{"date":"2026-05-15","current":15.411472,"twenty":17.905982,"median":23.228171,"eighty":40.949874,"marketCap":12844244741},{"date":"2026-05-22","current":14.974161,"twenty":17.865495,"median":23.159496,"eighty":40.903688,"marketCap":12479779870},{"date":"2026-05-29","current":15.51703,"twenty":17.794093,"median":23.031304,"eighty":40.696323,"marketCap":12932219020},{"date":"2026-06-05","current":15.830689,"twenty":17.72762,"median":22.976544,"eighty":40.649215,"marketCap":13193628306},{"date":"2026-06-12","current":16.135299,"twenty":17.677365,"median":22.910312,"eighty":40.520049,"marketCap":13447496940},{"date":"2026-06-18","current":15.815609,"twenty":17.660523,"median":22.794995,"eighty":40.339215,"marketCap":13181060552},{"date":"2026-06-26","current":16.053868,"twenty":17.618489,"median":22.608952,"eighty":40.029841,"marketCap":13379631068},{"date":"2026-07-02","current":16.274032,"twenty":17.615894,"median":22.524547,"eighty":39.347145,"marketCap":13563120278},{"date":"2026-07-10","current":17.221039,"twenty":17.587238,"median":22.397431,"eighty":37.962212,"marketCap":14352375239},{"date":"2026-07-17","current":16.792775,"twenty":17.541673,"median":22.296526,"eighty":36.938865,"marketCap":13995451021},{"date":"2026-07-24","current":16.783727,"twenty":17.523027,"median":22.203786,"eighty":36.596054,"marketCap":13987910368},{"date":"2026-07-31","current":16.880237,"twenty":17.497396,"median":22.134447,"eighty":36.439357,"marketCap":14068343995},{"date":"2026-08-07","current":15.028885,"twenty":17.477953,"median":21.975427,"eighty":36.110725,"marketCap":12934204322},{"date":"2026-08-14","current":14.571109,"twenty":17.441235,"median":21.877568,"eighty":35.783336,"marketCap":12540231432},{"date":"2026-08-21","current":15.457871,"twenty":17.393,"median":21.779709,"eighty":35.430434,"marketCap":13303399043},{"date":"2026-08-28","current":15.909889,"twenty":17.338011,"median":21.718547,"eighty":35.186291,"marketCap":13692416299},{"date":"2026-09-04","current":17.024099,"twenty":17.306151,"median":21.60979,"eighty":34.914013,"marketCap":14651331447},{"date":"2026-09-11","current":16.534653,"twenty":17.27586,"median":21.565643,"eighty":34.84302,"marketCap":14230102571},{"date":"2026-09-18","current":16.839837,"twenty":17.248105,"median":21.521169,"eighty":34.731487,"marketCap":14492751165},{"date":"2026-09-25","current":16.684366,"twenty":17.21742,"median":21.475871,"eighty":34.632422,"marketCap":14358949051},{"date":"2026-10-02","current":16.681487,"twenty":17.183072,"median":21.44327,"eighty":34.587848,"marketCap":14356471234},{"date":"2026-10-06","current":16.943485,"twenty":17.14408,"median":21.43512,"eighty":34.570682,"marketCap":14581952574}],"updateTime":1791419041294},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EXEL\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1111683139","title":"Movement Alert｜Exelixis Rises 5.54% in Regular Trading, Trading at $52.88","url":"https://stock-news.laohu8.com/highlight/detail?id=1111683139","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111683139?lang=en_us&edition=fundamental","pubTime":"2026-05-29 00:16","pubTimestamp":1779984972,"startTime":"0","endTime":"0","summary":"On May 28, Exelixis rose 5.54% in regular trading, trading at $52.88 USD/share, with trading volume of $61.21 million.Within the Biotechnology sector where Exelixis belongs, individual stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638654507","title":"Exelixis (EXEL) Valuation Check After ASCO 2026 Data Spotlight And New Merck Trial Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2638654507","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638654507?lang=en_us&edition=fundamental","pubTime":"2026-05-28 12:38","pubTimestamp":1779943086,"startTime":"0","endTime":"0","summary":"Exelixis (EXEL) has put fresh attention on its oncology pipeline after announcing extensive CABOMETYX and zanzalintinib data presentations at the 2026 ASCO meeting, along with a new colorectal cancer trial collaboration with Merck.\nSee our latest analysis for Exelixis.\nThe recent ASCO spotlight and Merck collaboration come after a strong run in the stock, with a 30 day share price return of 12.05% and a 3 year total shareholder return of 159.49%. This suggests that momentum has been building...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/exelixis-exel-valuation-check-after-asco-2026-data-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/exelixis-exel-valuation-check-after-asco-2026-data-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638964635","title":"Exelixis to webcast investor conference fireside chats in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2638964635","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638964635?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:06","pubTimestamp":1779912392,"startTime":"0","endTime":"0","summary":"Exelixis management will join a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL4d22wl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4552","IE0004091025.USD","LU0942090050.USD","LU0096364046.USD","LU2237443622.USD","LU0345770308.USD","EXEL","BK4504","LU1868837136.USD","IE00B19Z3581.USD","LU2750360641.GBP","LU0345770993.USD","LU1791807156.HKD","LU2237443382.USD","GSX","LU2471134879.HKD","BK4127","LU2471134952.CNY","BK4550","LU0742534661.SGD","IE0002270589.USD","LU0251131958.USD","LU0251142724.SGD","BK4588","IE00B19Z3B42.SGD","LU2237443465.HKD","LU2750360997.AUD","IE0034235188.USD","IE0004086264.USD","LU2471134523.USD","LU1668664300.SGD","IE00BSNM7G36.USD","BK4532","LU0106831901.USD","LU1804176565.USD","BK4533","BK4585","LU1894683348.USD","LU1868836914.USD","LU1868837300.USD","LU2237438978.USD","LU0061475181.USD","LU2265009873.SGD","BK4516","BK4139","LU0048573561.USD","LU1868836757.USD","LU1894683264.USD","LU2237443978.SGD","LU2471134796.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637355342","title":"Exelixis EVP Commercial Patrick J. Haley sells 32,110 shares for $1.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637355342","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637355342?lang=en_us&edition=fundamental","pubTime":"2026-05-23 05:02","pubTimestamp":1779483735,"startTime":"0","endTime":"0","summary":"Exelixis EVP, Commercial Patrick J. Haley sold 32,110 common shares on May 20, 2026 at an average price of USD 49.81.Haley held 357,638 shares following the sale, according to the filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL8Cjmn0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Exelixis EVP Commercial Patrick J. Haley sells 32,110 shares for $1.6 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352760","title":"Exelixis to present Cabometyx, zanzalintinib studies at ASCO annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352760","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352760?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397235,"startTime":"0","endTime":"0","summary":"Exelixis will present data on cabozantinib and investigational zanzalintinib at the 2026 American Society of Clinical Oncology Annual Meeting, May 29 to June 2, in Chicago.Key readouts include new analyses from the phase 3 CABINET trial for cabozantinib, with additional results from the phase 3 STELLAR-303 trial evaluating zanzalintinib in metastatic colorectal cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via Business Wire  on May 21, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL1KD1pD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4532","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637358480","title":"How Investors May Respond To Exelixis (EXEL) Merck MRD+ Colorectal Cancer Trial Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2637358480","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637358480?lang=en_us&edition=fundamental","pubTime":"2026-05-21 23:45","pubTimestamp":1779378307,"startTime":"0","endTime":"0","summary":"Earlier in May 2026, Exelixis announced a clinical development collaboration with Merck, under which Exelixis will sponsor the planned phase 3 STELLAR-316 trial testing its investigational kinase inhibitor zanzalintinib with and without Merck’s subcutaneous KEYTRUDA QLEX in resected stage II/III colorectal cancer patients who are molecular residual disease–positive after definitive therapy.\nThe partnership, which also incorporates Natera’s Signatera assay to identify eligible MRD+ patients,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/how-investors-may-respond-to-exelixis-exel-merck-mrd-colorec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/how-investors-may-respond-to-exelixis-exel-merck-mrd-colorec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1069347547.HKD","LU2125909593.SGD","LU2433249047.HKD","LU2491049909.HKD","BK4516","IE00BBT3K403.USD","LU1291159041.SGD","BK4139","LU2112291526.USD","LU2360032135.SGD","SG9999013999.USD","LU0965509010.AUD","LU1934455194.USD","SG9999001440.SGD","LU1923622614.USD","LU1941712264.USD","IE00B1BXHZ80.USD","LU1941712348.USD","LU1929549753.HKD","LU1093756168.USD","LU0211331839.USD","LU2361044949.HKD","LU1699723380.USD","LU0965509101.SGD","LU0477156953.USD","SG9999001176.SGD","LU1934455863.HKD","IE00BLSP4239.USD","LU1061106388.HKD","LU0106261372.USD","LU1066051811.HKD","LU0234572021.USD","LU2361045086.USD","LU0203347892.USD","LU1116320737.USD","LU2106854487.HKD","MRK","LU2023250504.SGD","LU2125154778.USD","LU2125909247.SGD","IE0009355771.USD","LU1917777945.USD","LU2357627491.SGD","SG9999001176.USD","LU0861579265.USD","LU1037948541.HKD","LU0868494708.USD","LU1116320901.HKD","LU1934455277.USD","LU2468319806.SGD","LU1162221912.USD","LU1983299246.USD","IE0002141913.USD","SGXZ57979304.SGD","BK4534","LU1585245621.USD","LU0965509283.SGD","LU2361044865.SGD","IE00BJT1NW94.SGD","LU0942090050.USD","LU2324357040.USD","LU2491050154.USD","LU1989771016.USD","LU0122379950.USD","LU2023250843.SGD","LU0203345920.USD","SG9999002224.SGD","SG9999014567.USD","LU0265550946.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","LU1066051225.USD","SG9999014575.USD","LU0208291251.USD","IE00BN8TJ469.HKD","LU0098860793.USD","LU1201861249.SGD","IE000M9KFDE8.USD","IE00B2B36J28.USD","BK4532","LU2461242641.AUD","LU1057294990.SGD","LU1035773651.USD","LU1430594728.SGD","LU0868494617.USD","LU0980610538.SGD","LU2491050071.SGD","LU1037948897.HKD","IE00BSNM7G36.USD","LU0265550359.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","LU0432979614.USD","BK4559","BK4211","LU1974910355.USD","LU0006306889.USD","SG9999014542.SGD","BK4550","IE00BLSP4452.SGD","SG9999002232.USD","LU1989772923.USD","LU0648001328.SGD","LU1066053197.SGD","LU0130517989.USD","LU0859254822.USD","LU0320765646.SGD","LU0985320562.USD","LU2089984988.USD","LU1571399168.USD","LU0266013472.USD","LU0320765489.SGD","SG9999015358.SGD","BK4007","LU0965508806.USD","LU0070302665.USD","IE00BFTCPJ56.SGD","SG9999015341.SGD","LU1093756325.SGD","BK4533","LU2125154935.USD","LU1023059063.AUD","LU0058720904.USD","LU0238689110.USD","LU0130102774.USD","EXEL","BK4588","LU1989772840.SGD","BK4585","SG9999014559.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636891974","title":"Top Exelixis Executive Cashes In on Major Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2636891974","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636891974?lang=en_us&edition=fundamental","pubTime":"2026-05-20 10:16","pubTimestamp":1779243362,"startTime":"0","endTime":"0","summary":"New insider activity at Exelixis ( ($EXEL) ) has taken place on May 19, 2026. Exelixis has reported a notable insider transaction as EVP & CFO Chri...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-exelixis-executive-cashes-in-on-major-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-exelixis-executive-cashes-in-on-major-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636686041","title":"Exelixis EVP, CFO Christopher Senner disposes 75,793 shares for $3.78 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2636686041","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636686041?lang=en_us&edition=fundamental","pubTime":"2026-05-20 06:59","pubTimestamp":1779231557,"startTime":"0","endTime":"0","summary":"Exelixis EVP and CFO Christopher J. Senner disposed of 75,793 common shares in transactions dated May 15 and May 18.40,892 shares were withheld at USD 51.1 to cover taxes tied to RSU vesting.Senner also sold 34,901 shares at a weighted average price of USD 50.Directly held common shares fell to 952,317 following the transactions.He also reported 2,723 shares held indirectly through a 401 plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL4BM6jX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Exelixis EVP, CFO Christopher Senner disposes 75,793 shares for $3.78 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636415860","title":"Exelixis SVP, General Counsel Brenda Hefti disposes 13,036 shares worth $662,202.55","url":"https://stock-news.laohu8.com/highlight/detail?id=2636415860","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636415860?lang=en_us&edition=fundamental","pubTime":"2026-05-20 06:59","pubTimestamp":1779231549,"startTime":"0","endTime":"0","summary":"Exelixis SVP and General Counsel Brenda Hefti reported a reduction in her common stock stake through share dispositions in mid-May.Sold 6,625 shares on May 18 at a weighted average price of $50.21.Withheld 6,411 shares on May 15 at $51.1 to cover taxes tied to RSU vesting.Reported direct ownership of 106,762 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL5P4Rm9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636185964","title":"Merck to Collaborate With Exelixis on Phase 3 Colorectal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2636185964","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636185964?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:50","pubTimestamp":1779195006,"startTime":"0","endTime":"0","summary":"Merck  has signed an agreement with Exelixis  to supply it with the Keytruda QLEX injection for a phase 3 trial in patients with resected stage 2/3 colorectal cancer, Exelixis said Tuesday.The trial will evaluate Exelixis' zanzalintinib oral kinase inhibitor in combination with and without Keytruda QLEX in patients who, following definitive therapy, have tested positive for molecular residual disease and have no radiographic evidence of disease, Exelixis said.The primary endpoint of the trial will be disease-free survival, with key secondary endpoints including circulating tumor DNA clearance, the company said.Exelixis added that the trial is expected to commence in mid-2026.Exelixis shares were up 1.4% in Tuesday's premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","LU1934455863.HKD","LU2360032135.SGD","LU0942090050.USD","LU0203345920.USD","IE00BBT3K403.USD","LU2125154935.USD","LU2023250843.SGD","LU0965508806.USD","SG9999001440.SGD","LU2106854487.HKD","LU1066051498.USD","BK4007","LU1069347547.HKD","IE00BSNM7G36.USD","LU1934455194.USD","LU2433249047.HKD","LU0130102774.USD","LU1093756325.SGD","LU2491050154.USD","LU0868494708.USD","LU1066051811.HKD","BK4559","LU1923622614.USD","LU1929549753.HKD","LU1116320901.HKD","LU0965509101.SGD","LU0432979614.USD","LU0006306889.USD","LU0985320562.USD","MRK","LU1941712348.USD","LU0265550946.USD","SG9999014575.USD","SG9999001176.SGD","LU1934455277.USD","LU1989772923.USD","IE0002141913.USD","LU0211331839.USD","LU1585245621.USD","IE00BJT1NW94.SGD","LU0106261372.USD","LU1037948541.HKD","LU0130517989.USD","IE00B2B36J28.USD","LU0203347892.USD","BK4550","LU1057294990.SGD","BK4534","BK4585","LU0320765646.SGD","LU0266013472.USD","LU2361044865.SGD","LU1699723380.USD","SG9999014567.USD","LU1066053197.SGD","SG9999013999.USD","SG9999002224.SGD","LU0265550359.USD","IE000M9KFDE8.USD","LU1571399168.USD","IE00B4R5TH58.HKD","BK4516","LU1066051225.USD","LU2112291526.USD","LU0477156953.USD","IE00BN8TJ469.HKD","LU0238689110.USD","LU2361045086.USD","LU2491049909.HKD","BK4532","LU1201861249.SGD","LU1162221912.USD","LU2461242641.AUD","LU0980610538.SGD","SG9999014542.SGD","LU1974910355.USD","LU1983299246.USD","LU2125154778.USD","SG9999001176.USD","LU0058720904.USD","LU2468319806.SGD","LU0098860793.USD","LU2125909593.SGD","SG9999015358.SGD","LU2023250504.SGD","IE00BJJMRZ35.SGD","LU1093756168.USD","BK4588","LU1291159041.SGD","EXEL","LU0289739699.SGD","LU0234572021.USD","LU0965509010.AUD","LU2125909247.SGD","LU1023059063.AUD","IE00B1BXHZ80.USD","LU0868494617.USD","BK4533","LU1037948897.HKD","LU0648001328.SGD","LU2491050071.SGD","LU1941712264.USD","LU1989772840.SGD","LU2357627491.SGD","LU1116320737.USD","LU2089984988.USD","LU0070302665.USD","SG9999015341.SGD","LU1430594728.SGD","LU1035773651.USD","IE00BLSP4452.SGD","LU0965509283.SGD","LU0208291251.USD","LU0320765489.SGD","LU1989771016.USD","IE00BFTCPJ56.SGD","BK4139","LU2361044949.HKD","LU0859254822.USD","LU0122379950.USD","LU0861579265.USD","LU1061106388.HKD","SG9999002232.USD","LU1917777945.USD","SG9999014559.SGD","SGXZ57979304.SGD","IE0009355771.USD","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636855775","title":"Exelixis partners with Merck on phase 3 colorectal cancer trial combining zanzalintinib, Keytruda Qlex","url":"https://stock-news.laohu8.com/highlight/detail?id=2636855775","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636855775?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:07","pubTimestamp":1779192445,"startTime":"0","endTime":"0","summary":"Exelixis entered a clinical development collaboration with Merck for the planned Phase 3 STELLAR-316 pivotal trial in resected stage II/III colorectal cancer.Merck will supply KEYTRUDA QLEX  for subcutaneous use in combination with zanzalintinib.Exelixis will sponsor STELLAR-316, which will test zanzalintinib with or without KEYTRUDA QLEX in patients who are molecular residual disease-positive with no radiographic evidence of disease.The primary endpoint is disease-free survival, with circulating tumor DNA clearance as a key secondary endpoint.Exelixis expects to start the trial in mid-2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL4rYWfC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014575.USD","LU2023250504.SGD","LU0203347892.USD","LU1983299246.USD","LU1941712348.USD","LU1934455194.USD","LU2125154935.USD","LU1989772840.SGD","LU2361044865.SGD","LU2491050071.SGD","SG9999001176.USD","LU0432979614.USD","LU1037948897.HKD","LU0320765646.SGD","LU0320765489.SGD","LU1035773651.USD","LU0965508806.USD","LU0965509283.SGD","SG9999015341.SGD","LU0130517989.USD","LU2023250843.SGD","EXEL","LU2361044949.HKD","IE00BLSP4239.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU0203345920.USD","LU0130102774.USD","LU1934455863.HKD","IE00BLSP4452.SGD","IE00B2B36J28.USD","BK4533","LU0942090050.USD","SG9999002232.USD","LU1201861249.SGD","LU1023059063.AUD","LU1116320737.USD","LU1934455277.USD","LU0965509010.AUD","LU0208291251.USD","LU0985320562.USD","LU0861579265.USD","BK4532","LU2468319806.SGD","LU0058720904.USD","BK4550","LU0234572021.USD","LU0477156953.USD","LU0106261372.USD","LU2112291526.USD","LU2125909247.SGD","LU1585245621.USD","LU1093756325.SGD","LU2324357040.USD","SG9999001440.SGD","SG9999014567.USD","BK4534","LU2461242641.AUD","LU2125154778.USD","LU2357627491.SGD","LU0868494617.USD","SG9999013999.USD","LU0265550359.USD","LU1066051225.USD","LU1941712264.USD","LU1061106388.HKD","LU2089984988.USD","SG9999001176.SGD","LU1066053197.SGD","LU1571399168.USD","LU1923622614.USD","LU0238689110.USD","IE00BBT3K403.USD","SG9999014559.SGD","IE00BFTCPJ56.SGD","LU1066051498.USD","SGXZ57979304.SGD","LU1116320901.HKD","LU2491050154.USD","BK4516","LU2433249047.HKD","LU1057294990.SGD","SG9999002224.SGD","IE0002141913.USD","LU0006306889.USD","IE00BJJMRZ35.SGD","LU2491049909.HKD","IE000M9KFDE8.USD","LU1430594728.SGD","LU1989772923.USD","LU1699723380.USD","LU2360032135.SGD","BK4585","LU0266013472.USD","LU2361045086.USD","LU1929549753.HKD","LU1162221912.USD","LU1989771016.USD","LU0122379950.USD","LU0868494708.USD","IE0009355771.USD","LU0211331839.USD","LU1037948541.HKD","LU1069347547.HKD","BK4139","LU1066051811.HKD","LU0289739699.SGD","LU1291159041.SGD","LU1917777945.USD","IE00BN8TJ469.HKD","LU0859254822.USD","SG9999015358.SGD","LU0648001328.SGD","IE00B1BXHZ80.USD","LU0098860793.USD","LU2125909593.SGD","LU0965509101.SGD","BK4588","LU0980610538.SGD","LU0070302665.USD","LU1093756168.USD","LU2106854487.HKD","MRK","IE00B4R5TH58.HKD","BK4007","LU0265550946.USD","BK4559","LU1974910355.USD","SG9999014542.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636855998","title":"Exelixis Inc - Expects to Initiate Stellar-316 in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2636855998","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636855998?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:00","pubTimestamp":1779192004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA3G6C13:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EXEL","BK4139","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636785599","title":"Exelixis Inc - Merck to Supply Keytruda Qlex for Stellar-316 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2636785599","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636785599?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:00","pubTimestamp":1779192004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA3G6C13:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636559688","title":"Exelixis Announces Clinical Development Collaboration With Merck for Phase 3 Stellar-316 Pivotal Trial for Patients With Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2636559688","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636559688?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:00","pubTimestamp":1779192004,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUA3G6C13:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636070193","title":"Exelixis Advances Zanzalintinib Into Phase 2 Meningioma Trial, Signaling Pipeline Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2636070193","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636070193?lang=en_us&edition=fundamental","pubTime":"2026-05-19 00:31","pubTimestamp":1779121870,"startTime":"0","endTime":"0","summary":"Exelixis ($EXEL) announced an update on their ongoing clinical study. Exelixis has launched a new Phase 2 trial called “A Phase 2, Single-Arm, Mult...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exelixis-advances-zanzalintinib-into-phase-2-meningioma-trial-signaling-pipeline-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exelixis-advances-zanzalintinib-into-phase-2-meningioma-trial-signaling-pipeline-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4139","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634549847","title":"Exelixis director Mary C. Beckerle disposes 7,712 shares for $373,646.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2634549847","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634549847?lang=en_us&edition=fundamental","pubTime":"2026-05-09 07:04","pubTimestamp":1778281462,"startTime":"0","endTime":"0","summary":"Exelixis director Mary C. Beckerle sold 7,712 common shares on May 7 at USD 48.45, cutting direct holdings to 17,524 shares.She also exercised options for 3,856 shares at USD 23.24 on same day, lifting direct holdings to 25,236 shares before sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL3xz68B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634427498","title":"Exelixis Director Maria C. Freire disposes 20,634 shares for $949,164","url":"https://stock-news.laohu8.com/highlight/detail?id=2634427498","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634427498?lang=en_us&edition=fundamental","pubTime":"2026-05-09 07:04","pubTimestamp":1778281460,"startTime":"0","endTime":"0","summary":"Exelixis director Maria C. Freire exercised stock options for 20,634 shares on May 7, 2026 at USD 19.77.Freire sold 20,634 shares on same day at USD 46.Common stock beneficial ownership fell to 100,819 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL4CWdYp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634498478","title":"Exelixis director George Poste disposes 60,000 shares for $2.74 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634498478","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634498478?lang=en_us&edition=fundamental","pubTime":"2026-05-09 07:04","pubTimestamp":1778281457,"startTime":"0","endTime":"0","summary":"Exelixis director George Poste sold 60,000 common shares on May 7 at weighted average price of $45.71.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exelixis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL8TLknN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Exelixis director George Poste disposes 60,000 shares for $2.74 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633740831","title":"Exelixis to webcast investor conference fireside chats in May","url":"https://stock-news.laohu8.com/highlight/detail?id=2633740831","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633740831?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:35","pubTimestamp":1778186127,"startTime":"0","endTime":"0","summary":"Exelixis management scheduled for investor-conference fireside chats on May 12, May 19, May 20, May 27.Sessions include BofA Securities Health Care Conference in Las Vegas, RBC Global Healthcare Conference in New York, Stifel Virtual Targeted Oncology Forum.Bernstein Annual Strategic Decisions Conference set for New York on May 27.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL68Fll2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130518102.USD","LU0648000940.SGD","IE00BZ1G4Q59.USD","LU1880398471.USD","BAC","IE00BLSP4239.USD","LU2129689605.HKD","BK4581","LU1496350171.SGD","LU0070302665.USD","IE00BKVL7J92.USD","BK4532","LU0130102774.USD","LU0306807586.USD","LU0321505868.SGD","IE00B1BXHZ80.USD","BK4504","LU1668664300.SGD","LU0477156797.USD","LU0106831901.USD","LU0203345920.USD","LU1201861249.SGD","LU1894683264.USD","LU1074936037.SGD","LU1280957306.USD","LU0310800965.SGD","LU0640476718.USD","LU0149725797.USD","LU0053666078.USD","LU0980610538.SGD","EXEL","IE00B19Z3B42.SGD","LU1035773651.USD","LU0256863811.USD","LU0256863902.USD","IE00B7SZLL34.SGD","LU1880398554.USD","LU0648001328.SGD","LU0208291251.USD","LU2133065610.SGD","BK4207","BK4139","IE00BLSP4452.SGD","LU0203347892.USD","IE0002270589.USD","IE0034235188.USD","LU2129689431.USD","IE00BFXG1179.USD","LU0130517989.USD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633143806","title":"Exelixis Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2633143806","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633143806?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:49","pubTimestamp":1778150940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EXEL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 07, 2026 06:49 ET (10:49 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":155,"code":"91000000","status":"200"}]}}